HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 51 filers reported holding HARPOON THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $710 | -4.6% | 1,000,000 | 0.0% | 0.02% | -50.0% |
| Q1 2023 | $744 | +2.5% | 1,000,000 | 0.0% | 0.04% | +7.3% |
| Q4 2022 | $726 | -99.9% | 1,000,000 | 0.0% | 0.04% | 0.0% |
| Q3 2022 | $970,000 | -49.2% | 1,000,000 | 0.0% | 0.04% | -59.8% |
| Q2 2022 | $1,910,000 | -61.6% | 1,000,000 | 0.0% | 0.10% | -51.0% |
| Q1 2022 | $4,970,000 | -34.2% | 1,000,000 | 0.0% | 0.21% | +1.5% |
| Q4 2021 | $7,550,000 | -4.4% | 1,000,000 | 0.0% | 0.20% | +15.8% |
| Q3 2021 | $7,900,000 | -43.0% | 1,000,000 | 0.0% | 0.18% | -37.2% |
| Q2 2021 | $13,870,000 | -33.7% | 1,000,000 | 0.0% | 0.28% | -23.8% |
| Q1 2021 | $20,920,000 | +57.4% | 1,000,000 | +25.0% | 0.37% | +29.8% |
| Q4 2020 | $13,288,000 | -2.2% | 800,000 | 0.0% | 0.28% | -13.6% |
| Q3 2020 | $13,592,000 | -9.0% | 800,000 | -11.1% | 0.33% | -21.1% |
| Q2 2020 | $14,940,000 | +7.5% | 900,000 | -25.0% | 0.42% | -28.8% |
| Q1 2020 | $13,896,000 | +10.5% | 1,200,000 | +41.2% | 0.59% | +20.8% |
| Q4 2019 | $12,572,000 | – | 850,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
| MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
| New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
| Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
| EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
| Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
| Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
| Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
| Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |